ID   SR8
AC   CVCL_JL55
DR   Wikidata; Q54955634
RX   PubMed=8695226;
RX   PubMed=10540202;
CC   Doubling time: 29 hours (PubMed=8695226; PubMed=10540202).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
CH   CVCL_JL56 ! SR8CT
//
RX   PubMed=8695226; DOI=10.1016/0959-8049(95)00549-8;
RA   Han, Xin
RA   Papadopoulos, Andreas J.
RA   Jones, Tania A.
RA   Sheer, Denise
RA   Raju, Kankipati S.
RT   "SR8 -- the establishment and characterisation of a new ovarian
RT   carcinoma cell line and xenograft model.";
RL   Eur. J. Cancer 32A:160-167(1996).
//
RX   PubMed=10540202; DOI=10.1046/j.1440-1711.1999.00840.x;
RA   Han, Xin
RA   Papadopoulos, Andreas J.
RA   Jones, Tania A.
RA   Devaja, Omer
RA   Raju, Kankipati S.
RT   "Cholera toxin-induced alteration of the phenotype and behaviour of an
RT   ovarian carcinoma cell line, SR8.";
RL   Immunol. Cell Biol. 77:377-384(1999).
//